| Identification |
| Name: | 19-Norpregn-4-en-20-yn-3-one,17-hydroxy-7-methyl-, (7a,17a)- |
| Synonyms: | 19-Nor-17a-pregn-4-en-20-yn-3-one,17-hydroxy-7a-methyl-(7CI,8CI); 17a-Ethynyl-17-hydroxy-7a-methyl-4-estren-3-one; 17b-Hydroxy-17a-ethynyl-7a-methylestr-4-en-3-one; 7a-Methyl-17a-ethynyl-19-nortestosterone; 7a-Methylnorethindrone; NSC 142228;Org-OM 38; D4-Tibolone |
| CAS: | 1162-60-3 |
| Molecular Formula: | C21H28 O2 |
| Molecular Weight: | 312.45 |
| InChI: | InChI=1/C21H28O2/c1-4-21(23)10-8-18-19-13(2)11-14-12-15(22)5-6-16(14)17(19)7-9-20(18,21)3/h1,12-13,16-19,23H,5-11H2,2-3H3 |
| Molecular Structure: |
 |
| Properties |
| Flash Point: | 192.7°C |
| Boiling Point: | 452.5°Cat760mmHg |
| Density: | 1.13g/cm3 |
| Refractive index: | 1.569 |
| Flash Point: | 192.7°C |
| Usage: | A metabolite of Tibolone. A synthetic steroid with weak estrogenic, androgenic and progestogenic activity. A pharamceutical used in the treatment of menopausal syndrome |
| Safety Data |
| |
 |
